Kawthar A. Mohamed
Prince Albert, SK, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
In vitro pharmacological activity of twenty-eight synthetic cannabinoid receptor agonists at the type 1 and 2 cannabinoid receptors.
Journal: Neurochemistry international
Published: July 03, 2025
Discovery of reversible monoacylglycerol lipase (MAGL) inhibitors based on ortho-hydroxyanilide scaffold.
Journal: Bioorganic chemistry
Published: June 04, 2025
In Vitro Signaling Properties of Cannabinoid and Orexin Receptors: How Orexin Receptors Influence Cannabinoid Receptor-Mediated Signaling.
Journal: Pharmacology research & perspectives
Published: June 07, 2024
New Insights into Bitopic Orthosteric/Allosteric Ligands of Cannabinoid Receptor Type 2.
Journal: International journal of molecular sciences
Published: November 30, 2022
Design, Synthesis, and Biological Activity of New CB2 Receptor Ligands: from Orthosteric and Allosteric Modulators to Dualsteric/Bitopic Ligands.
Journal: Journal of medicinal chemistry
Published: July 18, 2022
Design, synthesis and biological evaluation of novel orthosteric-allosteric ligands of the cannabinoid receptor type 2 (CB2R).
Journal: Frontiers in chemistry
Published: July 01, 2022
Novel Potent and Selective Agonists of the GPR55 Receptor Based on the 3-Benzylquinolin-2(1H)-One Scaffold.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: May 13, 2022
Synthesis and In Vitro Characterization of Selective Cannabinoid CB2 Receptor Agonists: Biological Evaluation against Neuroblastoma Cancer Cells.
Journal: Molecules (Basel, Switzerland)
Published: April 05, 2022
In vitro and in vivo pharmacological activity of minor cannabinoids isolated from Cannabis sativa.
Journal: Scientific reports
Published: October 06, 2020
Variously substituted 2-oxopyridine derivatives: Extending the structure-activity relationships for allosteric modulation of the cannabinoid CB2 receptor.
Journal: European journal of medicinal chemistry
Published: September 01, 2020
The Endocannabinoid System and Synthetic Cannabinoids in Preclinical Models of Seizure and Epilepsy.
The Endocannabinoid System and Synthetic Cannabinoids in Preclinical Models of Seizure and Epilepsy.
Journal: Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society
Published: January 03, 2020
Indomethacin Enhances Type 1 Cannabinoid Receptor Signaling.
Journal: Frontiers in molecular neuroscience
Published: July 01, 2019
Showing 1-12 of 12
Last Updated: 09/26/2026